| Company Name | Whan In Pharm. Co., Ltd. | Date Founded | June 5th, 1978 |
|---|---|---|---|
| Date Listed | July 3rd, 1996 | Chief Executive Officers | Chairman Kwangsik Lee, CEO & President Wonbum Lee |
| Representative Business Field |
Drug Manufacturing and Sales | Total Stocks Issued | 18,600,070 shares (Face Value: KRW 500) |
| Capital | KRW 9.7 Billion | Date of Settlement | December 31st |
| Headquarter's Address | 8F~11F, Whanin Building, 11, Beobwon-ro 6-gil, Songpa-gu, Seoul | Primary Phone | 02-405-3000 |
| Sector | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Ethical Drug | 98.7% | 99.1% | 99.6% | 98.5% | 99.4% |
| Over-the-counter Drug | 1.3% | 0.9% | 0.4% | 0.2% | 0.2% |
| Others | - | - | - | - | 0.4% |
| Total | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
[Unit: Million KRW]
| Category | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Central Nervous System | 121,346 | 130,076 | 141,936 | 144,182 | 155,251 |
| Cardiovascular | 9,692 | 9,328 | 10,428 | 10,904 | 12,052 |
| Gastrointestinal | 8,937 | 6,255 | 3,967 | 4,719 | 5,299 |
| Osteoporosis | 5,172 | 4,668 | 4,390 | 4,911 | 4,189 |
| Analgesics | 3,612 | 4,076 | 3,948 | 4,178 | 6,023 |
| Others | 5,441 | 4,902 | 6,428 | 7,478 | 11,444 |
| Total | 154,664 | 159,177 | 171,327 | 177,084 | 194,258 |
